Ovidrel Related Published Studies
Well-designed clinical trials related to Ovidrel (Choriogonadotropin Alfa)
Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro fertilization-embryo transfer. [2001.07]
Well-designed clinical trials possibly related to Ovidrel (Choriogonadotropin Alfa)
Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF. [2010.11]
Safety and efficacy of mixing cetrorelix with follitropin alfa: a randomized study. [2010.06]
Patient and nurse evaluation of recombinant human follicle-stimulating hormone administration methods: comparison of two follitropin injection pens. [2008.03]
Recombinant human luteinizing hormone, lutropin alfa, for the induction of follicular development and pregnancy in profoundly gonadotrophin-deficient women. [2007.10]
The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles: a double-blind, randomized, prospective study. [2006.01]
Do reproductive hormones modify insulin sensitivity and metabolism in older men? A randomized, placebo-controlled clinical trial of recombinant human chorionic gonadotropin. [2003.01]
A double-blind, placebo-controlled, randomized clinical trial of recombinant human chorionic gonadotropin on muscle strength and physical function and activity in older men with partial age-related androgen deficiency. [2002.07]
A prospective, randomized, controlled, double-blind, double-dummy comparison of recombinant and urinary HCG for inducing oocyte maturation and follicular luteinization in ovarian stimulation. [2000.06]
Other research related to Ovidrel (Choriogonadotropin Alfa)
Efficacy of luteinizing hormone activity in patients undergoing in vitro fertilization and treated only with low-dose recombinant choriogonadotropin alfa (Ovidrel) in the late follicular phase. [2006.10]
Other possibly related research studies
Continued improvements in the quality and consistency of follitropin alfa, recombinant human FSH. [2005.02]
Gateways to clinical trials. [2004.12]
Routine use of r-hFSH follitropin alfa filled-by-mass for follicular development for IVF: a large multicentre observational study in the UK. [2004.12]
Gateways to clinical trials. [2004.05]
Growing Teratoma syndrome treated by interferon alpha-2beta: case report and literature review. [2004.01]
[The role of tumor markers in the treatment of germ cell tumor] [2001.08]
Human chorionic gonadotropin and CA 15-3 producing adenocarcinoma. [1998]
Treatment of malignant carcinoid tumors with recombinant interferon alfa-2b: development of neutralizing interferon antibodies and possible loss of antitumor activity. [1989.04.05]
Patient experience with follitropin alfa prefilled pen versus previously used injectable gonadotropins for ovulation induction in oligoanovulatory women. [2006.10]
Improving the consistency of ovarian stimulation: follitropin alfa filled-by-mass. [2006.06]
Predictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alfa) during assisted reproduction technology (ART) procedures. An analysis of 1378 patients. [2006.05]
Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. [1995.05]
Age-matched comparison of recombinant and urinary HCG for final follicular maturation. [2006.09]
[Testicular malignant tumours. Efficacy of germ cell and sex cord tumours treatment protocol in Poland] [2006.07]
Adding human menopausal gonadotrophin to antagonist protocols - is there a benefit? [2007.08]
Bupropion: a review of its use in the management of major depressive disorder. [2008]
Outcomes of new quality standards of follitropin alfa on ovarian stimulation: meta-analysis of previous studies. [2009]
Corifollitropin alfa, a long-acting follicle-stimulating hormone agonist for the treatment of infertility. [2009.04]
Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f): long-term treatment in azoospermic men with hypogonadotropic hypogonadism. [2009.09]
[Case of far-advanced retroperitoneal extra-gonadal germ cell tumor responding to intensive treatment including multi-drug chemotherapy with peripheral blood stem cell transplantation and residual tumor removal] [2010.03]
An observational study of assisted reproductive technology outcomes in new European Union member states: an overview of protocols used for ovarian stimulation. [2010.04]
Absorption, distribution, metabolism and excretion of corifollitropin alfa, a recombinant hormone with a sustained follicle-stimulating activity. [2010]
A comparison of menotropin, highly-purified menotropin and follitropin alfa in cycles of intracytoplasmic sperm injection. [2009.10.14]
Corifollitropin alfa: a review of its use in controlled ovarian stimulation for assisted reproduction. [2011.08.01]
Gateways to clinical trials. [2010.09]
Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study. [2010.09.15]
[Case of far-advanced retroperitoneal extra-gonadal germ cell tumor responding to intensive treatment including multi-drug chemotherapy with peripheral blood stem cell transplantation and residual tumor removal]. [2010.03]
Corifollitropin alfa in a long GnRH agonist protocol: proof of concept trial. [2010.10]
Factors related to successful ovulation induction in patients with WHO group II anovulatory infertility. [2010.02]
Factors related to successful ovulation induction in patients with WHO group II
anovulatory infertility. [2010]
Safety and efficacy of mixing cetrorelix with follitropin alfa: a randomized
study. [2010]
|